BioTelemetry (BEAT) Tops Q2 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
July 30, 2020 4:05 PM EDTMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended June 30, 2020.
Company Highlights
Recognized quarterly total revenue of $99.1 millionTotal revenue declined 11.4% year-over-year due to the impact of COVID-19 across most of our businessesReported quarterly GAAP net income of $2.3 million, or 2.3% of total revenueRealized quarterly adjusted EBITDA of $25.6 million, or 25.8% of total revenueAcquired Remote... More